Thomas Callender
Overview
Explore the profile of Thomas Callender including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
2114
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Callender T, Payne K, Pashayan N, Mackie A
BMJ
. 2025 Feb;
388:e081098.
PMID: 40000108
No abstract available.
2.
Moore C, Frangou E, McCartan N, Santaolalla A, Kopcke D, Brembilla G, et al.
BMJ Oncol
. 2025 Jan;
2(1):e000057.
PMID: 39886504
Objective: In men with a raised prostate-specific antigen (PSA), MRI increases the detection of clinically significant cancer and reduces overdiagnosis, with fewer biopsies. MRI as a screening tool has not...
3.
Qian Z, Callender T, Cebere B, Janes S, Navani N, van der Schaar M
Sci Rep
. 2024 Oct;
14(1):25676.
PMID: 39463411
Synthetic data promise privacy-preserving data sharing for healthcare research and development. Compared with other privacy-enhancing approaches-such as federated learning-analyses performed on synthetic data can be applied downstream without modification, such...
4.
Giddings R, Joseph A, Callender T, Janes S, van der Schaar M, Sheringham J, et al.
Lancet Digit Health
. 2024 Jan;
6(2):e131-e144.
PMID: 38278615
Machine learning (ML)-based risk prediction models hold the potential to support the health-care setting in several ways; however, use of such models is scarce. We aimed to review health-care professional...
5.
Callender T, Imrie F, Cebere B, Pashayan N, Navani N, van der Schaar M, et al.
PLoS Med
. 2023 Oct;
20(10):e1004287.
PMID: 37788223
Background: Risk-based screening for lung cancer is currently being considered in several countries; however, the optimal approach to determine eligibility remains unclear. Ensemble machine learning could support the development of...
6.
Callender T, van der Schaar M
Lancet Digit Health
. 2023 Apr;
5(5):e254-e256.
PMID: 37100541
No abstract available.
7.
Conrad N, Verbeke G, Molenberghs G, Goetschalckx L, Callender T, Cambridge G, et al.
Lancet
. 2022 Aug;
400(10354):733-743.
PMID: 36041475
Background: Some autoimmune diseases are associated with an increased risk of cardiovascular disease. We aimed to determine whether or not this is true, and to what extent, for a broad...
8.
Callender T, Emberton M, Morris S, Pharoah P, Pashayan N
JAMA Netw Open
. 2021 Mar;
4(3):e2037657.
PMID: 33704474
Importance: If magnetic resonance imaging (MRI) mitigates overdiagnosis of prostate cancer while improving the detection of clinically significant cases, including MRI in a screening program for prostate cancer could be...
9.
Braithwaite I, Callender T, Bullock M, Aldridge R
Lancet Digit Health
. 2020 Aug;
2(11):e607-e621.
PMID: 32839755
Evidence for the use of automated or partly automated contact-tracing tools to contain severe acute respiratory syndrome coronavirus 2 is scarce. We did a systematic review of automated or partly...
10.
Pashayan N, Antoniou A, Ivanus U, Esserman L, Easton D, French D, et al.
Nat Rev Clin Oncol
. 2020 Jul;
17(11):716.
PMID: 32601456
An amendment to this paper has been published and can be accessed via a link at the top of the paper.